Insulin

A trusted partner providing end-to-end solutions from R&D to production and quality control, accelerating your pharmaceutical and biopharmaceutical applications

Designed for the purification of recombinant human insulin and its analogs. Combining ion exchange (for early-stage concentration) with reversed-phase silica chromatography resins (for fine purification), it achieves efficient separation of closely related structural isoforms such as deamidated variants.

Application Description

01

Insulin Purification Application Case

Insulin is a peptide hormone (approximately 7.5 KD) and one of the most important medications (injectable) for treating diabetes (Type I), one of the diseases affecting the largest patient population today. Therefore, it requires high purity and other technical specifications. Insulin drugs are classified into animal (bovine, porcine) insulin, (recombinant) human insulin, and insulin analogs (glargine, detemir, degludec, aspart, etc.). Their sources include animal tissue extraction, prokaryotic (E. coli) and eukaryotic (Pichia pastoris) fermentation.